These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 22362593)

  • 1. Genome-wide RNA interference analysis of renal carcinoma survival regulators identifies MCT4 as a Warburg effect metabolic target.
    Gerlinger M; Santos CR; Spencer-Dene B; Martinez P; Endesfelder D; Burrell RA; Vetter M; Jiang M; Saunders RE; Kelly G; Dykema K; Rioux-Leclercq N; Stamp G; Patard JJ; Larkin J; Howell M; Swanton C
    J Pathol; 2012 Jun; 227(2):146-56. PubMed ID: 22362593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA methylation of the SLC16A3 promoter regulates expression of the human lactate transporter MCT4 in renal cancer with consequences for clinical outcome.
    Fisel P; Kruck S; Winter S; Bedke J; Hennenlotter J; Nies AT; Scharpf M; Fend F; Stenzl A; Schwab M; Schaeffeler E
    Clin Cancer Res; 2013 Sep; 19(18):5170-81. PubMed ID: 23881922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of lactate/H⁺ symporters MCT1 and MCT4 and their chaperone CD147 predicts tumor progression in clear cell renal cell carcinoma: immunohistochemical and The Cancer Genome Atlas data analyses.
    Kim Y; Choi JW; Lee JH; Kim YS
    Hum Pathol; 2015 Jan; 46(1):104-12. PubMed ID: 25456395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monocarboxylate transporters MCT1 and MCT4 are independent prognostic biomarkers for the survival of patients with clear cell renal cell carcinoma and those receiving therapy targeting angiogenesis.
    Cao YW; Liu Y; Dong Z; Guo L; Kang EH; Wang YH; Zhang W; Niu HT
    Urol Oncol; 2018 Jun; 36(6):311.e15-311.e25. PubMed ID: 29657088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MCT4 surpasses the prognostic relevance of the ancillary protein CD147 in clear cell renal cell carcinoma.
    Fisel P; Stühler V; Bedke J; Winter S; Rausch S; Hennenlotter J; Nies AT; Stenzl A; Scharpf M; Fend F; Kruck S; Schwab M; Schaeffeler E
    Oncotarget; 2015 Oct; 6(31):30615-27. PubMed ID: 26384346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The two glycolytic markers GLUT1 and MCT1 correlate with tumor grade and survival in clear-cell renal cell carcinoma.
    Ambrosetti D; Dufies M; Dadone B; Durand M; Borchiellini D; Amiel J; Pouyssegur J; Rioux-Leclercq N; Pages G; Burel-Vandenbos F; Mazure NM
    PLoS One; 2018; 13(2):e0193477. PubMed ID: 29481555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SENP1 promotes proliferation of clear cell renal cell carcinoma through activation of glycolysis.
    Dong B; Gao Y; Kang X; Gao H; Zhang J; Guo H; You MJ; Xue W; Cheng J; Huang Y
    Oncotarget; 2016 Dec; 7(49):80435-80449. PubMed ID: 27741516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional screening identifies MCT4 as a key regulator of breast cancer cell metabolism and survival.
    Baenke F; Dubuis S; Brault C; Weigelt B; Dankworth B; Griffiths B; Jiang M; Mackay A; Saunders B; Spencer-Dene B; Ros S; Stamp G; Reis-Filho JS; Howell M; Zamboni N; Schulze A
    J Pathol; 2015 Oct; 237(2):152-65. PubMed ID: 25965974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective Inhibition of the Lactate Transporter MCT4 Reduces Growth of Invasive Bladder Cancer.
    Todenhöfer T; Seiler R; Stewart C; Moskalev I; Gao J; Ladhar S; Kamjabi A; Al Nakouzi N; Hayashi T; Choi S; Wang Y; Frees S; Daugaard M; Oo HZ; Fisel P; Schwab M; Schaeffeler E; Douglas J; Hennenlotter J; Bedke J; Gibb EA; Fazli L; Stenzl A; Black PC
    Mol Cancer Ther; 2018 Dec; 17(12):2746-2755. PubMed ID: 30262589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycolysis-Related Genes Serve as Potential Prognostic Biomarkers in Clear Cell Renal Cell Carcinoma.
    Zhang Y; Chen M; Liu M; Xu Y; Wu G
    Oxid Med Cell Longev; 2021; 2021():6699808. PubMed ID: 33564363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HSP60 silencing promotes Warburg-like phenotypes and switches the mitochondrial function from ATP production to biosynthesis in ccRCC cells.
    Teng R; Liu Z; Tang H; Zhang W; Chen Y; Xu R; Chen L; Song J; Liu X; Deng H
    Redox Biol; 2019 Jun; 24():101218. PubMed ID: 31112866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of monocarboxylate transporter-4 depletes stem-like glioblastoma cells and inhibits HIF transcriptional response in a lactate-independent manner.
    Lim KS; Lim KJ; Price AC; Orr BA; Eberhart CG; Bar EE
    Oncogene; 2014 Aug; 33(35):4433-41. PubMed ID: 24077291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The platelet isoform of phosphofructokinase contributes to metabolic reprogramming and maintains cell proliferation in clear cell renal cell carcinoma.
    Wang J; Zhang P; Zhong J; Tan M; Ge J; Tao L; Li Y; Zhu Y; Wu L; Qiu J; Tong X
    Oncotarget; 2016 May; 7(19):27142-57. PubMed ID: 27049827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monocarboxylate transporter 4, associated with the acidification of synovial fluid, is a novel therapeutic target for inflammatory arthritis.
    Fujii W; Kawahito Y; Nagahara H; Kukida Y; Seno T; Yamamoto A; Kohno M; Oda R; Taniguchi D; Fujiwara H; Ejima A; Kishida T; Mazda O; Ashihara E
    Arthritis Rheumatol; 2015 Nov; 67(11):2888-96. PubMed ID: 26213210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MCT4 as a potential therapeutic target for metastatic gastric cancer with peritoneal carcinomatosis.
    Lee JY; Lee I; Chang WJ; Ahn SM; Lim SH; Kim HS; Yoo KH; Jung KS; Song HN; Cho JH; Kim SY; Kim KM; Lee S; Kim ST; Park SH; Lee J; Park JO; Park YS; Lim HY; Kang WK
    Oncotarget; 2016 Jul; 7(28):43492-43503. PubMed ID: 27224918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MCT1 expression is independently related to shorter cancer-specific survival in clear cell renal cell carcinoma.
    de Carvalho PA; Bonatelli M; Cordeiro MD; Coelho RF; Reis S; Srougi M; Nahas WC; Pinheiro C; Leite KRM
    Carcinogenesis; 2021 Dec; 42(12):1420-1427. PubMed ID: 34668521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using the "reverse Warburg effect" to identify high-risk breast cancer patients: stromal MCT4 predicts poor clinical outcome in triple-negative breast cancers.
    Witkiewicz AK; Whitaker-Menezes D; Dasgupta A; Philp NJ; Lin Z; Gandara R; Sneddon S; Martinez-Outschoorn UE; Sotgia F; Lisanti MP
    Cell Cycle; 2012 Mar; 11(6):1108-17. PubMed ID: 22313602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of monocarboxylate transporter 4 in patients with esophageal squamous cell carcinoma.
    Cheng B; Chen X; Li Y; Huang X; Yu J
    Oncol Rep; 2018 Nov; 40(5):2906-2915. PubMed ID: 30226548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. hZIP1 that is down-regulated in clear cell renal cell carcinoma is negatively associated with the malignant potential of the tumor.
    Dong X; Kong C; Zhang Z; Liu X; Zhan B; Chen Z; Shi D
    Urol Oncol; 2014 Aug; 32(6):885-92. PubMed ID: 24878177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel 10 glycolysis-related genes signature could predict overall survival for clear cell renal cell carcinoma.
    Xing Q; Zeng T; Liu S; Cheng H; Ma L; Wang Y
    BMC Cancer; 2021 Apr; 21(1):381. PubMed ID: 33836688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.